Multicenter clinical trial of 111In-CYT-103 in patients with ovarian cancer.
Gallup
D G
DG
Medical College of Georgia, Augusta.
D000328:Adult; D000911:Antibodies, Monoclonal; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D009382:Neoplasms, Unknown Primary / Q000000981:diagnostic imaging; D009842:Oligopeptides; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging*; D004369:Pentetic Acid / Q000031:analogs & derivatives*; D016719:Radioimmunodetection / Q000009:adverse effects; D012680:Sensitivity and Specificity
D000911:Antibodies, Monoclonal; C063430:Indium 111In-satumomab pendetide; D007205:Indium Radioisotopes; D009842:Oligopeptides; D004369:Pentetic Acid